Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 98NIH 67INDUSTRY 17NETWORK 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Glioblastoma 1Central Nervous System Neoplasms 1Advanced Rare Tumours 1

Interventions

Radiotherapy 299Cisplatin 263Cyclophosphamide 229Doxorubicin 176Paclitaxel 166Vincristine 160Carboplatin 149Filgrastim 139Etoposide 139Gemcitabine 118Fluorouracil 113Docetaxel 112Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 91Leucovorin 90Granulocyte Colony-Stimulating Factor 74Specimen Handling 65Magnetic Resonance Spectroscopy 61Capecitabine 59Irinotecan 58Radiation 54Ifosfamide 51Oxaliplatin 48Daunorubicin 48Temozolomide 47Radiotherapy, Conformal 47Platinum 47Peripheral Blood Stem Cell Transplantation 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Interventional × temsirolimus × Clear all
NCT01396408 2026-03-27

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Canadian Cancer Trials Group

Phase 2 Active not recruiting
137 enrolled

Advanced Rare Tumours

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting
720 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT02343718 2023-08-04

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Canadian Cancer Trials Group

Phase 1 Completed
7 enrolled
Lymphoid

Lymphoma

NCT01019434 2018-07-09

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
111 enrolled
CNS

Glioblastoma, Central Nervous System Neoplasms

NCT00788580 2015-03-06

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡